Deleted Tweet from Scott Gottlieb, R-D.C.
Deleted Tweet from Scott Gottlieb, M.D.
SteveFDA (R-D.C.)
@SGottliebFDA
Politwoops no longer follows this account.
Seamless trials, used in oncology for drugs that might qualify for breakthrough therapy designation, are another novel approach https://t.co/yiOpoiLGJf. They compress the traditional 3 trial phases into one large, continuous trial that may be able to speed access for patients. https://t.co/JB1z8K3272
It looks like this tweet was replaced by the next tweet from @SGottliebFDA.